Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation
2019 ◽
Vol 54
(7)
◽
pp. 1158-1160
◽
2020 ◽
Vol 26
(5)
◽
pp. 943-948
2011 ◽
Vol 5
(1)
◽
pp. 127-135
◽
2016 ◽
Vol 10
(6)
◽
pp. 599-602
◽
2016 ◽
Vol 22
(4)
◽
pp. 710-716
◽
2015 ◽
Vol 21
(2)
◽
pp. S61-S62
◽
2014 ◽
Vol 89
(4)
◽
pp. 404-409
◽
2010 ◽
Vol 16
(2)
◽
pp. S157
◽
2018 ◽
Vol 24
(3)
◽
pp. S82-S83